MF
VIR icon

Magnetar Financial’s Vir Biotechnology VIR Stock Holding History

Magnetar Financial’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-41,891
Closed -$314K – 798
2024
Q3 		$314K Buy
41,891
+31,223
+293% +$271K 0.01% 400
2024
Q2 		$94.9K Buy
+10,668
New +$102K ﹤0.01% 487
2023
Q2 		– Sell
-9,954
Closed -$232K – 625
2023
Q1 		$232K Buy
+9,954
New +$255K ﹤0.01% 537
2022
Q1 		– Sell
-21,127
Closed -$885K – 1541
2021
Q4 		$885K Buy
+21,127
New +$828K 0.01% 833

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Magnetar Financial's VIR Position: Q4 2024 in Review

Magnetar Financial sold out of Vir Biotechnology (VIR) in Q4 2024, closing a stake of 41,891 shares — an estimated $314K sold.

Magnetar Financial first reported a position in VIR in Q4 2021 and held it in 4 quarters. The position peaked at $885K in Q4 2021. 208 funds tracked by Wall St. Rank hold VIR as of Q4 2024.

  • Magnetar Financial reported no remaining Vir Biotechnology position as of Q4 2024 after selling out during the quarter.
  • Magnetar Financial sold 41,891 Vir Biotechnology shares in Q4 2024, an estimated $314K.
  • Magnetar Financial first reported a position in Vir Biotechnology in Q4 2021 and held it in 4 quarters.
  • Magnetar Financial's Vir Biotechnology position peaked at $885K in Q4 2021.
  • 208 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2024.

Based on Magnetar Financial's 13F filing for Q4 2024, filed 11 Feb 2025.